integrating plasma testing for actionable mutations in mnsclc
Published 3 years ago • 243 plays • Length 2:58Download video MP4
Download video MP3
Similar videos
-
2:13
mnsclc with both pd-l1 and an actionable mutation
-
2:42
blood samples for detecting actionable oncogenic mutations in lung cancer
-
21:19
repeat biopsies & emerging technologies for plasma sampling of mutations
-
56:48
detection of therapeutically targetable mutations in nsclc:
-
53:55
advancing care for patients with egfr mutation–positive nsclc: precision medicine strategies
-
11:51
update | lung biopsy results & how i have been feeling
-
58:19
artificial intelligence-based biomarkers in precision oncology | jakob nikolas kather
-
3:52
black men develop lung cancer at a higher rate than other groups
-
9:23
mutation testing for all patients with nsclc
-
30:42
unlocking the power of genomic testing in nsclc: implementing personalized therapy to impact outcome
-
43:49
tumor molecular testing—making sense of new precision medicine testing options for cancer
-
4:28
mutation testing for advanced lung cancer
-
3:16
mutation testing in nsclc
-
56:48
webinar: detection of therapeutically targetable mutations in nsclc
-
38:41
part 2 - molecular and precision medicine (map) series
-
1:22
the identification of actionable mutations in lung cancer via ctdna
-
23:16
implementation of multigene testing for 1st line nsclc - a malaysian initiative
-
7:07
mutation testing in nsclc
-
6:09
mutation testing for nsclc
-
3:34
mutation testing in nonsquamous nsclc
-
9:37
precision medicine: targeted treatment for lung cancer
-
8:23
molecular testing in patients with resectable or metastatic nsclc | for the lung cancer nursing team